Valuation: Adimmune Corporation

Market Cap 7.19B 222M 195M 181M 167M 313M 21.5B 318M 2.17B 846M 10.48B 833M 815M 36.37B P/E 2024
-34.7x
P/E 2025 -33.2x
Enterprise Value 7.8B 241M 212M 197M 181M 339M 23.33B 346M 2.35B 918M 11.38B 904M 885M 39.47B EV / Sales 2024
5.53x
EV / Sales 2025 6.14x
Free-Float
70.19%
Yield 2024 *
-
Yield 2025 -
1 week-1.73%
Current month-3.12%
1 month-0.58%
3 months-4.75%
6 months-11.66%
Current year-10.03%
1 week 16.75
Extreme 16.75
17.75
1 month 16.65
Extreme 16.65
18.2
Current year 16.65
Extreme 16.65
21.5
1 year 16.65
Extreme 16.65
22.5
3 years 15.9
Extreme 15.9
36.6
5 years 15.9
Extreme 15.9
56.2
10 years 15.9
Extreme 15.9
79.8
Manager TitleAgeSince
Chief Executive Officer - 19/06/2019
Director of Finance/CFO - 31/12/2020
Chief Tech/Sci/R&D Officer - 25/01/2022
Director TitleAgeSince
Director/Board Member - 19/06/2019
Director/Board Member - 14/08/2011
Director/Board Member - 28/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.73%-2.85%-52.11% 222M
+0.11%-3.98%+13.89%-11.26% 66.25B
-0.12%+2.23%+36.63%+196.27% 52.86B
+0.51%+37.90%+37.90%+37.90% 43.01B
-1.03%-7.12%-57.51%-56.98% 39.52B
+1.46%-3.97%+53.17%-27.51% 29.19B
+0.78%+0.03%+65.07%+81.90% 23.13B
-1.81%-9.71%+64.46%-54.90% 23.04B
+0.38%+3.26%+4.14%+176.66% 20.48B
-1.04%-1.59%+66.57%+119.96% 16.6B
Average -0.03%-2.10%+28.15%+40.99% 31.43B
Weighted average by Cap. +0.00%-2.30%+25.28%+45.92%

Financials

2024 2025
Net sales 1.56B 48.09M 42.29M 39.29M 36.14M 67.77M 4.66B 68.98M 470M 183M 2.27B 181M 177M 7.88B 1.4B 43.29M 38.07M 35.37M 32.53M 61M 4.19B 62.09M 423M 165M 2.04B 163M 159M 7.09B
Net income -243M -7.5M -6.59M -6.13M -5.63M -10.57M -726M -10.75M -73.25M -28.57M -354M -28.15M -27.54M -1.23B -240M -7.41M -6.52M -6.05M -5.57M -10.44M -718M -10.63M -72.39M -28.24M -350M -27.81M -27.21M -1.21B
Net Debt 140M 4.31M 3.79M 3.52M 3.24M 6.07M 417M 6.18M 42.11M 16.43M 204M 16.18M 15.83M 706M 612M 18.91M 16.63M 15.45M 14.21M 26.65M 1.83B 27.13M 185M 72.07M 893M 70.99M 69.46M 3.1B
Logo Adimmune Corporation
Adimmune Corp is a Taiwan-based company mainly engaged in the research, development, processing, manufacturing, and sales of serums, vaccines, diagnostic reagents, biological agents, bacterial cultures, and raw materials. The Company's main products are influenza vaccines and non-influenza vaccines. Tetanus vaccines are used to prevent tetanus. Influenza vaccines are used to prevent seasonal influenza viruses. Tuberculin skin tests are used to determine whether a patient is infected with Mycobacterium tuberculosis. The Company primarily sells its products domestically and internationally.
Employees
564
Date Price Change Volume
23/07/26 NT$17.05 0.00% 2,313,567
22/07/26 NT$17.05 +0.29% 761,786
21/07/26 NT$17.00 +0.59% 592,815
20/07/26 NT$16.90 +0.60% 904,795
17/07/26 NT$16.80 -3.17% 1,458,918
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4142 Stock